Amprius Technologies (NYSE:AMPX) Stock Price Down 7.6% – Time to Sell?

Amprius Technologies, Inc. (NYSE:AMPX)’s stock price traded down 7.6% on Tuesday . The stock traded as low as $16.36 and last traded at $16.23. 1,396,685 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 8,782,408 shares. The stock had previously closed at $17.56.

Wall Street Analyst Weigh In

AMPX has been the topic of several recent analyst reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $20.00 price target on shares of Amprius Technologies in a research note on Tuesday, March 10th. Oppenheimer reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Amprius Technologies in a research note on Tuesday, December 23rd. B. Riley Financial upped their price target on Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, March 9th. Cantor Fitzgerald upped their price target on Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Finally, William Blair reaffirmed an “outperform” rating on shares of Amprius Technologies in a research note on Friday, March 6th. Eight research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $19.75.

Amprius Technologies Stock Performance

The company has a 50 day moving average of $14.15 and a 200-day moving average of $12.18. The stock has a market cap of $2.27 billion, a price-to-earnings ratio of -48.69 and a beta of 2.20.

Amprius Technologies (NYSE:AMPX) last posted its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.The firm had revenue of $25.23 million for the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. On average, research analysts anticipate that Amprius Technologies, Inc. will post -0.45 EPS for the current year.

Insider Transactions at Amprius Technologies

In other Amprius Technologies news, Director Kang Sun sold 1,500,000 shares of the stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $15.91, for a total value of $23,865,000.00. Following the sale, the director owned 1,342,400 shares of the company’s stock, valued at $21,357,584. This trade represents a 52.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Wen Hsuan Hsieh sold 413,146 shares of the stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $18.44, for a total value of $7,618,412.24. Following the completion of the sale, the director directly owned 44,444 shares in the company, valued at $819,547.36. This represents a 90.29% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 4,647,226 shares of company stock worth $65,744,047 in the last 90 days. Insiders own 12.90% of the company’s stock.

Institutional Investors Weigh In On Amprius Technologies

A number of hedge funds have recently bought and sold shares of the stock. Alberta Investment Management Corp acquired a new stake in Amprius Technologies in the 4th quarter valued at about $1,001,000. Vident Advisory LLC purchased a new position in shares of Amprius Technologies in the 4th quarter valued at about $107,000. Summit Securities Group LLC purchased a new position in shares of Amprius Technologies in the 4th quarter valued at about $54,000. Numerai GP LLC increased its holdings in shares of Amprius Technologies by 29.1% in the 4th quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock valued at $759,000 after acquiring an additional 21,698 shares during the last quarter. Finally, Osterweis Capital Management Inc. increased its holdings in shares of Amprius Technologies by 142.6% in the 4th quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock valued at $3,589,000 after acquiring an additional 267,385 shares during the last quarter. Institutional investors and hedge funds own 5.04% of the company’s stock.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.